drugset / Trial / NCT02157467

Study of Combined Oral Contraceptive Effects in Female Subjects

NCT02157467

Phase 1 Completed 46 enrolled ViiV Healthcare GlaxoSmithKline · collab
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to assess the effect of BMS-955176 on the pharmacokinetics of coadministered oral contraceptives.

Timeline

Start
2014-06-02
Primary completion
2014-08-25
Completion
2014-08-25

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-955176 Other / unclassified 80 mg
Subject Ortho-Cyclen Unknown Oral